Pulmonary capillary haemangiomatosis: a distinct entity?

Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani

Source: Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019
Journal Issue: June
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani. Pulmonary capillary haemangiomatosis: a distinct entity?. Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Pulmonary embolism and COVID-19: a “special phenotype”?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021

Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis
Source: Eur Respir Mon 2012; 57: 182-193
Year: 2012

Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017

Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Source: Eur Respir J 2010; 35: 223-224
Year: 2010

Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014

A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Pulmonary embolism with a rare etiology: a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired?
Source: Eur Respir J 2001; 18: Suppl. 33, 492s
Year: 2001

Propanolol treatment in pulmonary capillary hemangiomatosis
Source: Annual Congress 2011 - Rare lung diseases in children
Year: 2011

Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015

Secondary bronchogenic pulmonary hydatidosis: a rare entity
Source: Virtual Congress 2021 – Oncology, the mediastinum and infectious lung disease
Year: 2021

Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases?
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021

Multi nodular parenchymal pulmonary amyloidosis in primary Sjogren‘s syndrome: A case report
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Smoking-related intersticial fibrosis (srif): A new entity?
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011

Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018

Pulmonary embolism: still often underdiagnosed
Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases"
Year: 2017